Enrollment underway in Arcutis Bio's late-stage study of roflumilast foam in seborrheic dermatitis
July 12 2021 - 9:19AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Apr 2023 to Apr 2024